drugset / Trial / NCT00790608

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

NCT00790608

Phase 2 Terminated 8 enrolled Nitric BioTherapeutics, Inc
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.

Timeline

Start
2009-01
Primary completion
2009-05
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 1 % Topical